LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Replicate Assay Well Timepoint Timepoint Unit Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
MCF 10A Linsitinib
0.37
uM
LJP5
 2
O22
 72
hr
 1694 8781 11099 0.7911 0.8345
MCF 10A Linsitinib
0.37
uM
LJP5
 3
O22
 72
hr
 1694 9147 11168 0.8190 0.8585
MCF 10A Linsitinib
1.11
uM
LJP5
 1
O21
 72
hr
 1694 8529 11042 0.7724 0.8178
MCF 10A Linsitinib
1.11
uM
LJP5
 2
O21
 72
hr
 1694 8527 11099 0.7682 0.8147
MCF 10A Linsitinib
1.11
uM
LJP5
 3
O21
 72
hr
 1694 8576 11168 0.7679 0.8150
MCF 10A Linsitinib
3.33
uM
LJP5
 1
O20
 72
hr
 1694 7952 11042 0.7201 0.7714
MCF 10A Linsitinib
3.33
uM
LJP5
 2
O20
 72
hr
 1694 7742 11099 0.6975 0.7512
MCF 10A Linsitinib
3.33
uM
LJP5
 3
O20
 72
hr
 1694 8035 11168 0.7194 0.7720
MCF 10A Linsitinib
10
uM
LJP5
 1
O19
 72
hr
 1694 6456 11042 0.5847 0.6400
MCF 10A Linsitinib
10
uM
LJP5
 2
O19
 72
hr
 1694 6001 11099 0.5407 0.5942
MCF 10A Linsitinib
10
uM
LJP5
 3
O19
 72
hr
 1694 6349 11168 0.5685 0.6251
MCF 10A Ruxolitinib
0.04
uM
LJP5
 1
O18
 72
hr
 1694 10834 11042 0.9811 0.9860
MCF 10A Ruxolitinib
0.04
uM
LJP5
 2
O18
 72
hr
 1694 10812 11099 0.9741 0.9807
MCF 10A Ruxolitinib
0.04
uM
LJP5
 3
O18
 72
hr
 1694 10928 11168 0.9785 0.9841
MCF 10A Ruxolitinib
0.12
uM
LJP5
 1
O17
 72
hr
 1694 11261 11042 1.0198 1.0146
MCF 10A Ruxolitinib
0.12
uM
LJP5
 2
O17
 72
hr
 1694 10601 11099 0.9551 0.9664
MCF 10A Ruxolitinib
0.12
uM
LJP5
 3
O17
 72
hr
 1694 11344 11168 1.0157 1.0115
MCF 10A Ruxolitinib
0.37
uM
LJP5
 1
O16
 72
hr
 1694 11015 11042 0.9975 0.9982
MCF 10A Ruxolitinib
0.37
uM
LJP5
 2
O16
 72
hr
 1694 10607 11099 0.9556 0.9668
MCF 10A Ruxolitinib
0.37
uM
LJP5
 3
O16
 72
hr
 1694 11109 11168 0.9947 0.9961
MCF 10A Ruxolitinib
1.11
uM
LJP5
 1
O15
 72
hr
 1694 10673 11042 0.9666 0.9750
MCF 10A Ruxolitinib
1.11
uM
LJP5
 2
O15
 72
hr
 1694 10563 11099 0.9517 0.9638
MCF 10A Ruxolitinib
1.11
uM
LJP5
 3
O15
 72
hr
 1694 10663 11168 0.9548 0.9663
MCF 10A Ruxolitinib
3.33
uM
LJP5
 1
O14
 72
hr
 1694 10702 11042 0.9692 0.9770
MCF 10A Ruxolitinib
3.33
uM
LJP5
 2
O14
 72
hr
 1694 10440 11099 0.9406 0.9553